Search
Powered By HealthLine
Special Offers
Health Tools
 Heart Healthy Diet
 Ideal Body Weight Calculator
 Diet Reviews
 Fitness and Family
 Quiz: Test Your Fitness IQ
 Exercise and Fitness Guide
 Eat Out Smart
 Healthy Cooking
 BMI Calculator
Featured Conditions
 Diet & Exercise
 Stop Smoking
 Food & Fitness
 High Blood Pressure
 Cholesterol
 Heart
Resources
Healthscout News
3D Health Animations
Health Videos
Quizzes & Tools
Health Encyclopedia
In-Depth Reports
Library & Communities
News Archive
Drug Library
Find a Therapist
Enter City or Zip Code:
Powered by Psychology Today
PR Newswire
 Read latest







Channels
Home |  Today | Women| Men| Kids| Seniors| Diseases| Addictions| Sex & Relationships| Diet, Fitness, Looks| Alternative Medicine| Drug Checker
Medical Health Encyclopedia
 border=

Acute myelogenous leukemia (AML) - adult

VIDEO: Chemo booster cuts treatment time by two monthsSYMPTOMS: Learn what to look for and what the symptoms meanPROGNOSIS: Early detection and new treatments improve survival rates



Auer rods
Auer rods
Acute Monocytic Leukemia - Skin
Acute Monocytic Leukemia - Skin
Blood cells
Blood cells


Acute myelogenous leukemia (AML) - adult

Definition:

Acute myelogenous leukemia is a cancer of blood-forming tissues of the bone marrow. It is characterized by the growth of immature white blood cells. There are 8 categories of AML, categorized as M0 to M7, based on which blood cells are abnormal.

Alternative Names:
AML; Acute myeloid leukemia (AML); Acute granulocytic leukemia; Acute nonlymphocytic leukemia (ANLL); Leukemia - acute myeloid (AML); Leukemia - acute granulocytic; Leukemia - nonlymphocyctic (ANLL)

Text Continues Below



Causes, incidence, and risk factors:

Acute myelogenous leukemia (AML) may occur at any age, but it primarily affects adults and children younger than one year old. This discussion focuses on AML in adults. In this condition, certain blood cells of the immune system, which grow in the bone marrow, lose their ability to mature and specialize (differentiate). These cells multiply rapidly and replace normal blood cells.

Bone marrow failure occurs as malignant cells replace normal bone marrow. Patients with AML are susceptible to bleeding and infection as the normal blood cells lose their ability to fight microorganisms and decrease in number.

Most cases have no apparent cause. However, radiation, some toxins such as benzene, and some chemotherapy drugs (including etoposide and drugs known as alkylating agents) are thought to cause some kinds of leukemia, including AML. Genetic abnormalities may also play a role in the development of this condition.

Risk factors include the following:

  • exposure to radiation and chemicals
  • immunosuppression following organ transplantation
  • blood disorders such as:
    • Myeloproliferative diseases such as polycythemia vera or essential thrombocythemia
    • Myelodysplasia (refractory anemia)


A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org).

The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed physician should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. Copyright 2004 A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.

 







About The HealthScout Network Contact Us
Copyright © 2001-2009. The HealthCentralNetwork, Inc. All rights reserved.
Privacy Policy: Updated as of April 1, 2009  Terms of Service   Site Map
Advertising Policy